Timeline

Longitudinal observations found that circulating taurine did not consistently fall with age.

Ryoncil's approval concerns a specific pediatric graft-versus-host disease indication.

The agency restated that young plasma was not approved for the promoted wellness and disease uses.

A new model extends prediction to complexes involving proteins and other molecular components.

A Science study explored taurine and ageing across experimental species.

Researchers examined longer treatment schedules and molecular changes in ageing animals.

The company's launch announcement reported US$3 billion in committed capital.

DeepMind and EMBL-EBI released a public resource for structural biology.

The baseline report placed older people's functional ability and daily needs at the centre of the agenda.

Mayo Clinic announced early clinical observations in people with diabetes-related kidney disease.

A phase 1 study reported a retinal pigment epithelium patch for severe age-related eye disease.

A primary study characterized TMP-B from Tricholoma matsutake and investigated experimental biological activity.

A Salk study reported changes in aging markers in cells and a premature-aging mouse model.